Clinical Trials Browser

Phase 2 × Unresectable Locally Recurrent Breast Cancer × Breast × Clear all

NCT07497386 2026-03-27

A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer

Phase 2 Not yet recruiting

Unresectable Locally Recurrent Breast Cancer